

Regional regulatory affairs and pharmacovigilance leader with over 9 years in the pharmaceutical and medical device sectors. Promoted to cluster lead in January 2026, overseeing regulatory and pharmacovigilance activities across 16 countries. Currently managing a team of 9 professionals and a diverse portfolio of 313 products, including 290 medical devices and 23 pharmaceuticals. Recognized for enhancing regulatory governance and driving sustainable business growth while ensuring compliance and patient safety.
- Quality Management & Business Performance
- Managing Virtual/Remate Teams
- Organization Planning and Development for the 6a Blackbelt